Where is Proxygen's headquarters?

Proxygen is located in Vienna, Wien, Austria.

Who invested in Proxygen?

Proxygen is funded by Boehringer Ingelheim.

When was the last funding round for Proxygen?

Proxygen closed its last funding round on obfuscated from a Grant round.

Who are Proxygen's competitors?

Alternatives and possible competitors to Proxygen may include Amgen, Orionis Biosciences, And Degron Therapeutics.

Proxygen - Growth Outlook

Growth Outlook

Growth Score

updated Dec 26, 2023

-10 pts

in past quarter

Growth Performance Over Time

Score

Trend

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

Growth Insight

See this Growth Insight

Proxygen is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Companies with Similar Growth

Organization Name	Growth Score	Industries	Headquarters Location	Description
Temasek	80	Angel Investment, Finance, Financial Services, Impact Investing, Life Science, Venture Capital	Singapore, Central Region, Singapore	Temasek is an investment company that manages a diverse portfolio of assets across multiple asset classes and industries,
ARCH Venture Partners	84	Finance, Financial Services, Incubators, Life Science, Venture Capital	Chicago, Illinois, United States	ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.
Massive Bio	84	Artificial Intelligence (AI), Biotechnology, Clinical Trials, Health Care, Natural Language Processing	Boca Raton, Florida, United States	Massive Bio is building the world's largest global real time cancer registry with patient consented clinical and genomic data.
Alvotech	79	Biotechnology, Health Care, Life Science, Pharmaceutical	Reykjavík, Gullbringusysla, Iceland	Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines.
Humacyte	86	Biotechnology, Medical, Medical Device	Morrisville, North Carolina, United States	Humacyte develops products for vascular diseases and replacement of anatomical conduits.
Connecticut Innovations	87	Biotechnology, Business Development, Energy, Information Technology, Media and Entertainment, Venture Capital	Rocky Hill, Connecticut, United States	Connecticut Innovations provides strategic capital and operational insight to to companies in high-tech industries
Firefly Bio	85	Biotechnology, Life Science, Medical	San Francisco, California, United States	Firefly Bio is a biotechnology company that develops targeted cancer therapeutics based on antibody-drug conjugate (ADC) technology.
Verily	83	Analytics, Data Management, Enterprise Software, Health Care, Information Technology, Life Science	South San Francisco, California, United States	Verily is an Alphabet health tech company focused on research, care, and health financing to deliver on the promise of precision health.
Chai Discovery	78	Artificial Intelligence (AI), Foundational AI, Health Care, Life Science	San Francisco, California, United States	Chai Discovery develops artificial intelligence models that predict and reprogram biochemical molecule interactions.
eXoZymes	78	Artificial Intelligence (AI), Biofuel, Biotechnology, Pharmaceutical	Monrovia, California, United States	eXoZymes develops enzyme-based biomanufacturing solutions that use AI-enhanced, cell-free enzyme systems.